| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8773856 | Kidney International Reports | 2018 | 34 Pages |
Abstract
Combined administration of sucroferric oxyhydroxide and calcium carbonate at low doses was effective in maintaining serum phosphorus concentrations within the target range, and patients' gastrointestinal status improved. Sucroferric oxyhydroxide maintained its serum phosphorus-lowering effect with a decreased pill burden, and its concomitant administration with calcium carbonate was well tolerated.
Related Topics
Health Sciences
Medicine and Dentistry
Nephrology
Authors
Fumihiko Koiwa, Keitaro Yokoyama, Masafumi Fukagawa, Tadao Akizawa,